Over-expression of AQP7 contributes to improve insulin resistance in adipocytes

Experimental Cell Research

Volumn 318, Issue 18, 2012, Pages 2377-2384

  Shen, Fei Xia ^a   Gu, Xuemei ^a   Pan, Wei ^a   Li, Wei Ping ^b   Li, Wei ^c   Ye, Jing ^a   Yang, Li Juan ^a   Gu, Xue Jiang ^a   Ni, Lian Song ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b SHANTOU UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

3T3 L1 adipocytes; Aquaglyceroporin 7 (AQP7); Insulin resistance; PKB

Indexed keywords

ADENOVIRUS VECTOR; AQUAGLYCEROPORIN; AQUAGLYCEROPORIN 7; DEXAMETHASONE; GLYCEROL; MESSENGER RNA; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLUCOSE INTAKE; GLUCOSE TRANSPORT; INSULIN RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ADENOVIRIDAE;

EID: 84865296349     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.07.016     Document Type: Article

References (21)

1. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. The Lancet 2005, 365:1415-1428.
2. Eckel R.H., Alberti K., Grundy S.M., Zimmet P.Z. The metabolic syndrome. The Lancet 2010, 375:181-183.
3. Fruhbeck G. Obesity: aquaporin enters the picture. Nature 2005, 438:436-437.
4. Rodriguez A., Catalan V., Gomez-Ambrosi J., Fruhbeck G. Role of aquaporin-7 in the pathophysiological control of fat accumulation in mice. FEBS Lett. 2006, 580:4771-4776.
5. Wintour E.M., Henry B.A. Glycerol transport: an additional target for obesity therapy?. Trends Endocrinol. Metab. 2006, 17:77-78.
6. Hibuse T., Maeda N., Funahashi T., Yamamoto K., Nagasawa A., Mizunoya W., Kishida K., Inoue K., Kuriyama H., Nakamura T., Fushiki T., Kihara S., Shimomura I. Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. PNAS 2005, 102:10993-10998.
7. Rodríguez A., Catalán V., Gómez-Ambrosi J., Frühbeck G. Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control. Cell Cycle 2011, 10:1548-1556.
8. Maeda N., Hibuse T., Funahashi T., Beitz E. Role of aquaporin-7 and aquaporin-9 in glycerol metabolism; involvement in obesity. Handb. Exp. Pharmacol. 2009, 190:233-249.
9. Kondo H., Shimomura I., Kishida K., Kuriyama H., Makino Y., Nishizawa H., Matsuda M., Maeda N., Nagaretani H., Kihara S., Kurachi Y., Nakamura T., Funahashi T., Matsuzawa Y. Human aquaporin adipose (AQPap) gene. Eur. J. Biochem. 2002, 269:1814-1826.
10. Fruhbeck G., Catalan V., Gomez-Ambrosi J., Rodriguez A. Aquaporin-7 and glycerol permeability as novel obesity drug-target pathways. Trends Pharmacol. Sci. 2006, 27:345-347.
11. Fasshauer M., Klein J., Lossner U., Klier M., Kralisch S., Paschke R. Suppression of aquaporin adipose gene expression by isoproterenol, TNFα, and dexamethasone. Horm. Metab. Res. 2003, 35:222-227.
12. Kishida K., Kuriyama H., Funahashi T., Shimomura I., Kihara S., Ouchi N., Nishida M., Nishizawa H., Matsuda M., Takahashi M., Hotta K., Nakamura T., Yamashita S., Tochino Y., Matsuzawa Y. Aquaporin adipose, a putative glycerol channel in adipocytes. J. Biol. Chem. 2000, 275:20896-20902.
13. Virreira M., Perret J., Delporte C. Pancreatic beta-cells: role of glycerol and aquaglyceroporin 7. Int. J. Biochem. Cell Biol. 2010, 43:10-13.
14. MacDougald O.A., Burant C.F. Obesity and metabolic perturbations after loss of aquaporin 7, the adipose glycerol transporter. PNAS 2005, 102:10759-10760.
15. Kishida K., Shimomura I., Kondo H., Kuriyama H., Makino Y., Nishizawa H., Maeda N., Matsuda M., Ouchi N., Kihara S., Kurachi Y., Funahashi T., Matsuzawa Y. Genomic structure and insulin-mediated repression of the aquaporin adipose (AQPap), adipose-specific glycerol Channel. J. Biol. Chem. 2001, 276:36251-36260.
16. Rodriguez A., Catalan V., Gomez-Ambrosi J., Garcia-Navarro S., Rotellar F., Valenti V., Silva C., Gil M.J., Salvador J., Burrell M.A., Calamita G., Malagin M.M., Fruhbeck G. Insulin- and leptin-mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K/Akt/mTOR signaling cascade. J. Clin. Endocrinol. Metab. 2011, 96:E586-E597.
17. Walker C.G., Holness M.J., Gibbons G.F., Sugden M.C. Fasting-induced increases in aquaporin 7 and adipose triglyceride lipase mRNA expression in adipose tissue are attenuated by peroxisome proliferator-activated receptor [alpha] deficiency. Int. J. Obes. 2007, 31:1165-1171.
18. Kong C.-S., Kim J.-A., Bak S.-S., Byun H.-G., Kim S.-K. Anti-obesity effect of carboxymethyl chitin by AMPK and aquaporin-7 pathways in 3T3-L1 adipocytes. J. Nutr. Biochem. 2009, 22:276-281.
19. Hajduch E., Litherland G.J., Hundal H.S. Protein kinase B (PKB/Akt)-a key regulator of glucose transport?. FEBS Lett. 2001, 492:199-203.
20. Carvalho E., Rondinone C., Smith U. Insulin resistance in fat cells from obese Zucker rats-evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4. Mol. Cell. Biochem. 2000, 206:7-16.
21. Shao J., Yamashita H., Qiao L., Friedman J.E. Decreased Akt kinase activity and insulin resistance C57BL/KsJ-Lepr(db/db) mice. J. Endocrinol. 2000, 167:107-115.